Trial
NCT05487859
Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
Kidney Cancer
Intervention
Acarbose Tablets
Why stopped
due to overall cost of the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-17